Semaglutide Trial to Uncover Effects on Human Energy Expenditure
The Effect of Weekly Semaglutide Treatment on Energy Expenditure
Background
Obesity is a complex chronic disease characterized by excessive body fat, significantly increasing risks for numerous health complications. While GLP-1 agonists like semaglutide are highly effective for weight loss, the precise mechanisms, particularly their impact on overall energy expenditure, remain an area requiring deeper understanding. This study aims to fill that knowledge gap by rigorously evaluating how weekly semaglutide injections influence various energy expenditure metrics in individuals with obesity.